These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 236851)

  • 1. Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.
    Lal S; Aronoff A; Garelis E; Sourkes TL; Young SN; de la Vega CE
    Clin Neurol Neurosurg; 1975 Dec; 77(2):142-52. PubMed ID: 236851
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.
    Gagnieu MC; Menouni-Foray V; Guardiola P; Quincy C; Renaud B
    Clin Chim Acta; 1984 May; 139(1):1-12. PubMed ID: 6202442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
    Gottfries CG; Kjällquist A; Pontén U; Roos BE; Sundbärg G
    Br J Psychiatry; 1974 Mar; 124(0):280-7. PubMed ID: 4836896
    [No Abstract]   [Full Text] [Related]  

  • 4. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 5. Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury.
    Vecht CJ; van Woerkom CA; Teelken AW; Minderhoud JM
    Arch Neurol; 1975 Dec; 32(12):792-7. PubMed ID: 1203031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 7. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Shaywitz BA; Cohen DJ; Leckman JF; Young JG; Bowers MB
    Dev Med Child Neurol; 1980 Dec; 22(6):748-54. PubMed ID: 6161049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.
    Kartzinel R; Ebert MH; Chase TN
    Neurology; 1976 Oct; 26(10):992-6. PubMed ID: 134293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
    Sjöström R
    Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
    Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract]   [Full Text] [Related]  

  • 15. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 16. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.